192 related articles for article (PubMed ID: 20008439)
21. Inhibition of gastric carcinogenesis by the hormone gastrin is mediated by suppression of TFF1 epigenetic silencing.
Tomita H; Takaishi S; Menheniott TR; Yang X; Shibata W; Jin G; Betz KS; Kawakami K; Minamoto T; Tomasetto C; Rio MC; Lerkowit N; Varro A; Giraud AS; Wang TC
Gastroenterology; 2011 Mar; 140(3):879-91. PubMed ID: 21111741
[TBL] [Abstract][Full Text] [Related]
22. CpG island hypermethylation of multiple tumor suppressor genes associated with loss of their protein expression during rat lung carcinogenesis induced by 3-methylcholanthrene and diethylnitrosamine.
Liu WB; Ao L; Zhou ZY; Cui ZH; Zhou YH; Yuan XY; Xiang YL; Cao J; Liu JY
Biochem Biophys Res Commun; 2010 Nov; 402(3):507-14. PubMed ID: 20970405
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA 'signature' during estrogen-mediated mammary carcinogenesis and its reversal by ellagic acid intervention.
Munagala R; Aqil F; Vadhanam MV; Gupta RC
Cancer Lett; 2013 Oct; 339(2):175-84. PubMed ID: 23791885
[TBL] [Abstract][Full Text] [Related]
24. Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning.
Hinshelwood RA; Melki JR; Huschtscha LI; Paul C; Song JZ; Stirzaker C; Reddel RR; Clark SJ
Hum Mol Genet; 2009 Aug; 18(16):3098-109. PubMed ID: 19477956
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma.
Spugnardi M; Tommasi S; Dammann R; Pfeifer GP; Hoon DS
Cancer Res; 2003 Apr; 63(7):1639-43. PubMed ID: 12670917
[TBL] [Abstract][Full Text] [Related]
26. The intronic long noncoding RNA ANRASSF1 recruits PRC2 to the RASSF1A promoter, reducing the expression of RASSF1A and increasing cell proliferation.
Beckedorff FC; Ayupe AC; Crocci-Souza R; Amaral MS; Nakaya HI; Soltys DT; Menck CF; Reis EM; Verjovski-Almeida S
PLoS Genet; 2013; 9(8):e1003705. PubMed ID: 23990798
[TBL] [Abstract][Full Text] [Related]
27. Gene expression and epigenetic profiles of mammary gland tissue: insight into the differential predisposition of four rat strains to mammary gland cancer.
Luzhna L; Kutanzi K; Kovalchuk O
Mutat Res Genet Toxicol Environ Mutagen; 2015 Feb; 779():39-56. PubMed ID: 25813725
[TBL] [Abstract][Full Text] [Related]
28. Exposure to estrogen and ionizing radiation causes epigenetic dysregulation, activation of mitogen-activated protein kinase pathways, and genome instability in the mammary gland of ACI rats.
Kutanzi K; Kovalchuk O
Cancer Biol Ther; 2013 Jul; 14(7):564-73. PubMed ID: 23792640
[TBL] [Abstract][Full Text] [Related]
29. Specific overexpression of cyclin E·CDK2 in early preinvasive and primary breast tumors in female ACI rats induced by estrogen.
Weroha SJ; Lingle WL; Hong Y; Li SA; Li JJ
Horm Cancer; 2010 Feb; 1(1):34-43. PubMed ID: 21761349
[TBL] [Abstract][Full Text] [Related]
30. Dominant-negative histone H3 lysine 27 mutant derepresses silenced tumor suppressor genes and reverses the drug-resistant phenotype in cancer cells.
Abbosh PH; Montgomery JS; Starkey JA; Novotny M; Zuhowski EG; Egorin MJ; Moseman AP; Golas A; Brannon KM; Balch C; Huang TH; Nephew KP
Cancer Res; 2006 Jun; 66(11):5582-91. PubMed ID: 16740693
[TBL] [Abstract][Full Text] [Related]
31. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM
Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038
[TBL] [Abstract][Full Text] [Related]
32. Loss of DNA methylation and histone H4 lysine 20 trimethylation in human breast cancer cells is associated with aberrant expression of DNA methyltransferase 1, Suv4-20h2 histone methyltransferase and methyl-binding proteins.
Tryndyak VP; Kovalchuk O; Pogribny IP
Cancer Biol Ther; 2006 Jan; 5(1):65-70. PubMed ID: 16322686
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic progression of columnar cell lesions of the breast to invasive breast cancer.
Verschuur-Maes AH; de Bruin PC; van Diest PJ
Breast Cancer Res Treat; 2012 Dec; 136(3):705-15. PubMed ID: 23104224
[TBL] [Abstract][Full Text] [Related]
34. CpG island tumor suppressor promoter methylation in non-BRCA-associated early mammary carcinogenesis.
Vasilatos SN; Broadwater G; Barry WT; Baker JC; Lem S; Dietze EC; Bean GR; Bryson AD; Pilie PG; Goldenberg V; Skaar D; Paisie C; Torres-Hernandez A; Grant TL; Wilke LG; Ibarra-Drendall C; Ostrander JH; D'Amato NC; Zalles C; Jirtle R; Weaver VM; Seewaldt VL
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):901-14. PubMed ID: 19258476
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic alterations by methylation of RASSF1A and DAPK1 promoter sequences in mammary carcinoma detected in extracellular tumor DNA.
Ahmed IA; Pusch CM; Hamed T; Rashad H; Idris A; El-Fadle AA; Blin N
Cancer Genet Cytogenet; 2010 Jun; 199(2):96-100. PubMed ID: 20471512
[TBL] [Abstract][Full Text] [Related]
36. Long-term arsenic exposure induces histone H3 Lys9 dimethylation without altering DNA methylation in the promoter region of p16(INK4a) and down-regulates its expression in the liver of mice.
Suzuki T; Nohara K
J Appl Toxicol; 2013 Sep; 33(9):951-8. PubMed ID: 22733434
[TBL] [Abstract][Full Text] [Related]
37. Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines.
Harada K; Toyooka S; Maitra A; Maruyama R; Toyooka KO; Timmons CF; Tomlinson GE; Mastrangelo D; Hay RJ; Minna JD; Gazdar AF
Oncogene; 2002 Jun; 21(27):4345-9. PubMed ID: 12082624
[TBL] [Abstract][Full Text] [Related]
38. Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells.
Kim TY; Jong HS; Song SH; Dimtchev A; Jeong SJ; Lee JW; Kim TY; Kim NK; Jung M; Bang YJ
Oncogene; 2003 Jun; 22(25):3943-51. PubMed ID: 12813468
[TBL] [Abstract][Full Text] [Related]
39. Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma.
Lee MG; Kim HY; Byun DS; Lee SJ; Lee CH; Kim JI; Chang SG; Chi SG
Cancer Res; 2001 Sep; 61(18):6688-92. PubMed ID: 11559536
[TBL] [Abstract][Full Text] [Related]
40. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
Li Z; Zhang H; Yang J; Hao T; Li S
Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]